Case-control study of fetal microchimerism and breast cancer

PLoS ONE

Volumn 3, Issue 3, 2008, Pages

  Gadi, Vijayakrishna K ^a,b   Malone, Kathleen E ^a,b   Guthrie, Katherine A ^a,b   Porter, Peggy L ^a,b   Nelson, J Lee ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MICROCHIMERISM; PARITY; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; QUANTITATIVE ANALYSIS; REPRODUCTION; RISK ASSESSMENT; RISK FACTOR; BREAST TUMOR; CHIMERA; COMPARATIVE STUDY; CYTOLOGY; FETUS; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHIMERISM; DNA, NEOPLASM; FEMALE; FETUS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; PREGNANCY; PROGNOSIS; RISK FACTORS;

EID: 45849084304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001706     Document Type: Article

References (19)

1. Ganz PA (2005) Breast cancer, menopause, and long-term survivorship: critical issues for the 21st century. Am J Med 118: 136-141.
2. Chen S, Iversen FS, Friebel T, Finkelstein D, Weber BL, et al. (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24: 863-871.
3. McClain MR, Palomaki GE, Nathanson KI, Haddow JE (2005) Adjusting the estimated proportion of breast cancer cases associated with BRCAl and BRCA2 mutations: public health implications. Genet Med 7: 28-33.
4. Beral V (1983) Parity and susceptibility to cancer. Ciba Found Symp 96: 182-203.
5. Layde PM, Webster LA, Baughman AL, Wingo PA, Rubin GL, et al. (1989) The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 42: 963-973.
6. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, De Maria MA (1996) Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 93: 705-708.
7. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, et al. (1999) Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 93: 2033-2037.
8. Lambert NC, Lo YM, Erickson TD, Tylee TS, Guthrie KA, et al. (2002) Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 100: 2845-2851.
9. Lo YM, Lau TK, Chan LY, Leung TN, Chang AM (2000) Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 46: 1301-1309.
10. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, et al. (1998) Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351: 559-562.
11. Scaletti C, Vultaggio A, Bonifacio S, Emmi L, Torricelli F, et al. (2002) Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 46: 445-450.
12. Klintschar M, Schwaiger P, Mannweiler S, Regauer S, Kleiber M (2001) Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab 86: 2494-2498.
13. Weiden PI, Flournoy N, Thomas ED, Prentice R, Fefer A, et al. (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow gratfs. N Engl J Med 300: 1068-1073.
14. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED (1981) Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304: 1529-1533.
15. Tykodi SS, Warren EH, Thompson JA, Riddell SR, Childs RW, et al. (2004) Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. Clin Cancer Res 10: 7799-7811.
16. Gadi VK, Nelson JL (2007) Fetal microchimerism in women with breast cancer. Cancer Res 67: 9035-9038.
17. Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, et al. (1995) Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 87: 827-835.
18. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, et al. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491.
19. Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, et al. (2004) Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum 50: 906-914.